NCT01815762View on ClinicalTrials.gov

Extravascular Lung Water Monitoring by Combined Ultrasound and Bioimpedance as a Guide for Treatment in Hemodialysis Patients

NACompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Patients on Hemodialysis for More Than 3 Months
Interventions
OTHER

Active arm

"In the active arm of the study, the number of ultrasound lung comets (ULC) will directly adjust the prescribed post-hemodialysis dry weight. See study flowchart on page 1.~If the patient does not tolerate the intervention (as described above), he will continue the study in the medication arm, where the actual intervention in stopped, and extra cardio-protective drugs are added to the medication."

Trial Locations (1)

700503

"University Hospital Dr. C.I. Parhon, Iasi, Department of Nephrology", Iași

All Listed Sponsors
lead

Grigore T. Popa University of Medicine and Pharmacy

OTHER

NCT01815762 - Extravascular Lung Water Monitoring by Combined Ultrasound and Bioimpedance as a Guide for Treatment in Hemodialysis Patients | Biotech Hunter | Biotech Hunter